Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Holders of 5% or more of SCPS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Scopus BioPharma Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Scopus BioPharma Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Scopus BioPharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2022 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Nov 26, 2021 | HCFP/Capital Partners 18B-1 LLC | 13DOld format | – | – | – | SEC |
| Nov 26, 2021 | SCPS/Strategic Capital Partners LLC | 13D/AOld format | – | – | – | SEC |
| Nov 26, 2021 | HCFP/Capital Partners 18B-2 LLC | 13D/AOld format | – | – | – | SEC |
| Aug 12, 2021 | HCFP/Capital Partners 18B-2 LLC | 13DOld format | – | New | – | SEC |
| Aug 12, 2021 | SCPS/Strategic Capital Partners LLC | 13DOld format | – | New | – | SEC |
| Jul 13, 2021 | Kortylewski Marcin | 13GOld format | – | New | – | SEC |
| May 12, 2021 | Laster Morris C | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2021 | Laster Morris C | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | HCFP/Capital Partners 18B-1 LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Scopus BioPharma Inc. shares.
No Form 144 notices for Scopus BioPharma Inc. are on file.